|
Today's Headlines
Having reached the end of a 10-month injunction barring it from selling its botulinum toxin product in the U.S., Merz is once again launching Xeomin for the treatment of glabellar lines. » More
|
|
Intermittent dosing of vemurafenib extended the lives of lab mice with drug-resistant melanoma tumors, according to results of an international study. » More
|
|
fyi...
|
48% |
|
Percentage of patients with psoriasis who use social media regularly for support related to their disease
Source: National Psoriasis Foundation
|
|
|
ADVERTISEMENT
Dermatology Times' Laser and Light 2012 special supplement is available!
Read about today's hottest laser and light technologies by visiting:
 dermatologytimes.com/laserandlight2012 |
|
Patients with rheumatoid arthritis who use anti-tumor necrosis factor treatments may have an increased risk of shingles, according to researchers. » More
|
|
Atopic dermatitis coupled with food allergy in early childhood speeds up allergic progression, according to findings from a recent study. » More
|
|
|
Like
Tweet
